Track: Gastroenterology and Hepatology

Advances in Gastrointestinal Disorders

Irritable Bowel Syndrome (IBS): Investigating novel treatment options, including dietary interventions and pharmacotherapy. Emphasis will be placed on the role of the microbiome in IBS and its therapeutic implications.

Gastroesophageal Reflux Disease (GERD): Discussing new diagnostic tools and surgical advancements, with a focus on improving patient outcomes through personalized treatment strategies.

Colorectal Cancer: Examining the impact of screening programs and new biomarkers for early detection. Attention will be given to the role of genetics and personalized medicine in treatment approaches.

Liver Diseases and Hepatology

Chronic Hepatitis B and C: Reviewing advances in antiviral therapies and the global efforts to eliminate these infections. Special focus will be given to the role of novel drugs and vaccines.

Non-alcoholic Fatty Liver Disease (NAFLD): Discussing the growing epidemic of NAFLD, its progression to non-alcoholic steatohepatitis (NASH), and the potential for emerging pharmacological therapies.

Liver Transplantation: Analyzing the latest innovations in liver transplantation, including advances in donor organ preservation and immunosuppressive therapies, to improve graft survival and patient outcomes.

The Role of Endoscopy in Diagnosis and Treatment

Therapeutic Endoscopy: Highlighting the role of endoscopy in treating gastrointestinal bleeding, benign strictures, and early cancers.

Endoscopic Ultrasound (EUS): Exploring the diagnostic capabilities of EUS in evaluating pancreaticobiliary diseases and liver tumors, and its role in guiding biopsies and interventions.

5th World Congress on Global Healthcare and Medicine

Track: Gastroenterology and Hepatology

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at